Noile-Immune Biotech Inc
TSE:4893
Relative Value
The Relative Value of one Noile-Immune Biotech Inc stock under the Base Case scenario is 105.16 JPY. Compared to the current market price of 128 JPY, Noile-Immune Biotech Inc is Overvalued by 18%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Noile-Immune Biotech Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
JP |
N
|
Noile-Immune Biotech Inc
TSE:4893
|
5.5B JPY | 17.5 | -4.9 | 0 | 0 | |
US |
Abbvie Inc
NYSE:ABBV
|
279.6B USD | 5.1 | 47 | 13.2 | 20.4 | ||
US |
Amgen Inc
NASDAQ:AMGN
|
164.3B USD | 5.6 | 43.7 | 18.5 | 30.4 | ||
US |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
116.4B USD | 11.4 | 29 | 24.3 | 25.4 | ||
US |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
108B USD | 8.2 | 28 | 22.6 | 25.1 | ||
AU |
CSL Ltd
ASX:CSL
|
136.2B AUD | 6.4 | 36.5 | 22 | 27.3 | ||
US |
Gilead Sciences Inc
NASDAQ:GILD
|
82.5B USD | 3 | 170.4 | 8.7 | 11.4 | ||
US |
Moderna Inc
NASDAQ:MRNA
|
62.7B USD | 12.2 | -10.5 | -12 | -10.6 | ||
US |
Seagen Inc
NASDAQ:SGEN
|
43.1B USD | 18.8 | -57.5 | -61.9 | -55.8 | ||
US |
Biogen Inc
NASDAQ:BIIB
|
31.8B USD | 3.3 | 27.2 | 13.9 | 17.4 | ||
KR |
Celltrion Inc
KRX:068270
|
38T KRW | 16.4 | 96.8 | 48.7 | 81.4 |